What makes ergothioneine unusual
Ergothioneine (ET) is a thiol derivative of the amino acid histidine. Three facts set it apart from hundreds of "antioxidants in a jar":
- The body built a dedicated transporter for it — OCTN1 (gene SLC22A4). A transporter with that specificity is a luxury: evolution does not encode a protein for a junk molecule. Ergothioneine is actively taken up by cells and accumulates in tissues: erythrocytes, liver, eyes, brain.
- Humans cannot synthesize it — it comes only from food. And the only meaningful dietary source is mushrooms: button mushrooms, oyster mushrooms (especially tamogitake — the golden oyster, the content champion), shiitake. Outside mushrooms, sources are negligible.
- It persists in the body — in a 2017 pharmacokinetic study, pure ergothioneine in humans showed high uptake and retention (tissue retention measured in weeks, not hours), meaning it is not "in and out".
Taken together: a "vitamin-like substance" — there is a transporter, there is accumulation, there is a single dietary source. Some authors propose the status of a "longevity vitamin" in Bruce Ames's framework — a deficiency does not kill outright but shifts the trajectory of aging.
What has been measured in humans
Memory-clinic cohort (Singapore, 2022, PMID 36139790): 470 elderly patients, all with plasma ergothioneine measured, neuroimaging (cerebrovascular disease, brain atrophy) and up to 5 years of repeated cognitive testing. Result: the lower the baseline ET, the worse cognition at baseline and the faster the decline in memory, executive function, attention, speed and language — but only in the subgroup without dementia. Mediation analysis showed the effect of ET on cognition is largely explained by the severity of cerebrovascular disease (white-matter hyperintensities) and brain atrophy.
Pilot RCT in MCI (NCT03641404, published 2024): 19 patients aged 60+ with mild cognitive impairment, ergothioneine 25 mg three times a week for one year. Outcomes: completely safe; improvement on the auditory verbal learning test (RAVLT); stabilization of plasma neurofilament light — a marker of neuronal damage that rose in the placebo group. We have a card for this study.
Where the data ends
An honest frame for ergothioneine today:
- Shown in humans: absorbed and retained (PK-2017), correlates with cognitive trajectory (n=470 cohort), a year of supplementation is safe (n=19 pilot).
- Not shown in humans: that ergothioneine supplementation prevents dementia, slows aging or improves cognition in healthy people — the pilot was small and in a population already impaired.
- Causal uncertainty: low ET may be a marker, not a cause — a generally poor diet correlates with both low ET and disease. The mediation via cerebrovascular pathology hints that part of the effect is not "the molecule acts" but "the molecule marks a healthy diet".
Practical meaning
For the reader, the takeaway is down-to-earth: ergothioneine is an argument for mushrooms as food, not a reason to buy capsules. The richest culinary form is tamogitake (golden oyster), then common oyster mushrooms, shiitake and button mushrooms. The pilot dose (75 mg/week of pure substance) is unrealistically high to reach through food — regular mushroom eating provides less, but that is the level the transporter is evolutionarily "tuned" for.